Breast augmentation poses various risks, including:
- Scar tissue that distorts the shape of the breast implant (capsular contracture)
- Breast pain
- Changes in nipple and breast sensation, usually temporary
- Implant leakage or rupture
Correcting any of these complications might require additional surgery, either to remove or replace the implants.
The Food and Drug Administration (FDA) has identified a possible association between breast implants and the development of anaplastic large cell lymphoma (ALCL), a rare cancer of the immune system. The FDA believes that women with breast implants may have a very low but increased risk of developing ALCL. However, further research is needed to fully understand the relationship between ALCL and breast implants.
Jan. 12, 2018
- Neligan PC, et al. Breast augmentation. In: Core Procedures in Plastic Surgery. Philadelphia, Pa.: Elsevier; 2014. http://www.clinicalkey.com. Accessed May 18, 2015.
- Breast augmentation. American Society of Plastic Surgeons. http://www.plasticsurgery.org/cosmetic-procedures/breast-augmentation.html. Accessed May 18, 2015.
- Anaplastic large cell lymphoma (ALCL). U.S. Food and Drug Administration. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm239995.htm. Accessed May 18, 2015.
- Breast implants: Local complications and adverse outcomes. U.S. Food and Drug Administration. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/ucm259296.htm. Accessed May 18, 2015.
- Breast implant surgery. U.S. Food and Drug Administration. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm064176.htm. Accessed May 18, 2015.
- Golden AK. Decision Support System. Mayo Clinic, Rochester, Minn. April 22, 2015.
- Pruthi S (expert opinion). Mayo Clinic, Rochester, Minn. May 21, 2015.